Abstract
There is now much evidence to suggest that protein kinase-C (PKC) acts as a transducer element in cell-signalling processes following stimulation of membrane receptors linked to phospholipase(s)-C (PLC). Occupancy of such receptors by specific agonists (hormones, neurotransmitters, growth factors etc.) promotes hydrolysis by PLC of the membrane phospholipid, phosphatidylinositol 4,5 bisphosphate to yield the second-messengers inositol 1,4,5, trisphosphate (IP3) and 1,2, sn diacylglycerol (DAG). Because IP3 and DAG are rapidly metabolized, their intracellular levels are raised only transiently following receptor stimulation. However, in cells expressing certain oncogenes (e.g. NRK cells transformed with K-ras or sis) the resting levels are elevated, possibly because the oncogene products function as receptor-transducer elements (for review see Berridge, 1986). Being lipid soluble, DAG remains in the plasma membrane where it is available to activate PKC which translocates from the cytoplasm to the cell membrane following cell stimulation. The conformational change to specific intracellular proteins brought about through phosphorylation by PKC is an early event in a cascade of similar biochemical reactions that either propagate or abrogate the initial signal, leading to a variety of cellular responses. There are many examples where the activation of PKC augments cellular responses brought about by an increase in intracellular free Ca2+. However, there are also examples where activation of PKC, without a concomitant increase of Ca2+ above resting levels, also provokes a response (e.g. Di Virgilio et al., 1984). Thus, the contribution of PKC activity to cellular functions varies not only among different cell types but also between different functions within the same cell.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bazzi, M.D., and Nelsestuen, G.L. Role of substrate in imparting calcium and phospholipid requirements to protein kinase C activation. Biochemistry. 26:1974–1982, 1987a.
Bazzi, M.D. and Nelsestuen, G.L. Role of substrate in determining the phospholipid specificity of protein kinase C activation. Biochemistry. 26:5002–5008, 1987b.
Bazzi, M.D. and Nelsestuen, G.L. Association of protein kinase C with phospholipid vesicles. Biochemistry. 26: 115–122, 1987c.
Bazzi, M.D. and Nelsestuen, G.L. Mechanism of protein kinase C inhibition by sphingosine. Biochem. Biophys. Res. Comm. 146:203–207, 1987d.
Berridge, M.J. Intracellular signalling through inositol triphosphate and diacylglycerol. Biol. Chem. Hoppe Seyler. 367:447–456, 1986.
Blumberg, P.M., Jaken, S., Konig, B., Sharkey, N.A., Leach, K.L., Jeng, A.Y. and Yeh, E. Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands. Biochem. Pharmacol. 33:933–940, 1984.
Bonser, R.W., Thompson, N.T., Hodson, H.F., Beams, R.M. and Garland, L.G. Evidence that a second stereochemical centre in diacylglycerols defines interaction at the recognition site on protein kinase C. FEBS Letters. 234:341–344, 1988.
Conn, P.M., Ganong, B.R., Ebeling, J., Staley, D., Neidel, J.E. and Bell, R.M. Diacylglycerols release LH: structure-activity relations reveal a role for protein kinase C. Biochem. Biophys. Res. Comm. 126:532–539, 1985.
Di Virgilio, F., Lew, D.P. and Pozzan, T. Protein kinase C activation of physiological processes in human neutrophils at vanishingly small cytosolic Ca2+ levels. Nature. 310:691–693, 1984.
Ganong, B.R., Loomis, C.R., Hannun, Y.A. and Bell, R.M. Specificity and mechanism of protein kinase C activation by sn-1,2-diacylglycerols. Proc. Natl. Acad. Sci. USA. 83:1184–1188, 1986.
Hannun, Y.A. and Bell, R.M. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science. 235:670–673, 1987.
Hannun, Y.A., Loomis, C.R. and Bell, R.M. Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J. Biol Chem. 260:10039–10043, 1985.
Hannun, Y.A., Loomis, C.R. and Bell, R.M. Protein kinase C activation in mixed micelles. J. Biol Chem.. 261:7184–7190, 1986.
Hidaka, H., Inagaki, M., Kawamoto, S. and Saski, Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23:5036–5041, 1984.
House, C. and Kemp, B.E. Protein kinase C contains a pseudosubtrate prototope in its regulatory domain. Science. 238:1726–1728, 1987.
Kaibuchi, K., Takai, Y. and Nishizuka, Y. Cooperative roles various membrane phospholipids in the activation of calcium-activated, phospholipid-dependent protein kinase. J. Biol. Chem. 256:7146–7149, 1981.
Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A. and Kaneko, M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Comm. 142: 436–440, 1987.
Lambeth, J.D., Burnham, D.N. and Tyagi, S.R. Sphinganine effects on chemoattractant-induced diacylglycerol generation, calcium fluxes, superoxide production, and on cell viability in the human neutrophil. J. Biol. Chem. 263:3818–3822, 1988.
Lewis, M.J. and Henderson, A.H. A phorbol ester inhibits the release of endothelium-derived relaxing factor. Eur. J. Pharmacol. 137:167–171, 1987.
Loomis, C.R. and Bell, R.M. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.J. Biol. Chem.. 263:1682–1692, 1988.
Mackie, K., Lai, Y., Nairn, A.C., Greengard, P., Pitt, B.R. and Lazo, J.S. Protein phosphorylation in cultured endothelial cells. J. Cell Physiol. 128:367–374, 1986.
Ono, Y. and Kikkawa, U. Do multiple species of protein kinase C transduce different signals? Trends in Biochem. Sci. 12:421–423, 1987.
Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarashi, K. and Nishizuka, Y. Identification of three additional members of rat protein kinase C family: δ, ∊ — and ζ -subspecies. FEBS Letters. 226:125–128, 1987.
Palmer, R.M.J., Ferrige, A.G. and Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:524–526, 1987.
Pittet, D., Krause, K-H., Wollheim, C.B., Bruzzone, R. and Lew, D.P. Nonselective inhibition of neutrophil functions by sphinganine. J. Biol. Chem. 262:10072–10076, 1987.
Rando, R.R. and Young, N. The stereospecific activation of protein kinase C Biochem. Biophys. Res. Comm. 122:818–823, 1984.
Tamaoki, T., Nomoto, H., Takahashi, I., Kato, Y., Morimoto, M. and Tomita, F. Stauros-porine, a potent inhibitor of phospholipid/Ca+ + dependent protein kinase. Biochem. Biophys. Res. Comm. 135:397–402, 1986.
Thompson, N.T., Bonser, R.W., Hodson, H.F. and Garland, L.G. Ca2+-independent binding of 3H-phorbol dibutyrate to PKC is supported by protamine and other polycations. Biochem. J.. 255:412–422, 1988.
Watson, S.P. and Lapetina, E. 1,2-diacylglycerol and phorbol ester inhibit agonist-induced formation of inositol phosphates in human platelets: possible implications for negative feedback regulation of inositol phospholipid hydrolysis. Proc. Natl. Acad. Sci. USA. 82:2623–2626, 1985.
Watson, S.P., McNally, J., Shipman, L.J. and Godfrey, P.P. The action of the protein kinase C inhibitor, staurosporine, on human platelets: evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin. Biochem. J.. 249:345–350, 1988.
Weinheimer, G., Wagner, B and Osswald, H. Interference of phorbol esters with endothelium-dependent vascular smooth muscle relaxation. Eur. J. Pharmacol 130:319–322, 1986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Garland, L.G. (1989). Diacylglycerols and Protein Kinase-C. In: Catravas, J.D., Gillis, C.N., Ryan, U.S. (eds) Vascular Endothelium. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8532-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8532-5_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8534-9
Online ISBN: 978-1-4684-8532-5
eBook Packages: Springer Book Archive